Winning Investment - general investment

STOCKNUCLEUS · Tweet this Post! #1 (**permalink**) 01-31-2011, 09:06 PM

Neoprobe - up 40% in January - doubled each of the past few years. Applied to be listed just waiting for a response any day. Has well over the minimum requirements. Lymphoseek will save lives by detecting any cancer that may have spread to the lymph nodes, 20-30x's more effective, Blue-dye was never tested by the FDA and has many safety concerns attached.

Read more on Neoprobe and other market news @
Stock Nucleus

Stock Nucleus

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode